MGLL and neoplasm: To validate the specificity of JN-PROTAC for MAGL-expressing tumor cells, we assessed MAGL expression across various cell lines, including normal human astrocytes, GBM stem cells, mouse melanoma (B16F10), and human breast tumor (MDA-MB-231) cells.